According to an updated report by the World Health Organization, cardiovascular diseases are the leading cause of death worldwide. Data from the World Heart Federation show that they are the most common non-communicable diseases. In Saudi Arabia, the economic burden associated with cardiovascular diseases is projected to triple by 2035. In Australia, heart disease are found in 4% of the population. Nuclear medicine plays an important role in the early detection and treatment of these diseases. According to GLOBOCAN 2021, the number of new cancer cases in the world is expected to increase to 30.2 million by 2040, which also increases the demand for radioisotopes for radiation therapy.
Statistics
Expansion of opportunities. Innovation. Progress.
-
Expanding opportunities
The cyclotron facility in Uzbekistan will expand access to various radioisotopes, opening up new opportunities for medical diagnostics and therapy, as well as for industrial and scientific applications.
-
Innovation
The advanced technologies that will be used in the cyclotron complex will allow the introduction of innovative methods and products in the field of nuclear medicine and related fields.
-
Progress
The project implementation will be an important step forward for Uzbek science, medicine and industry, strengthening the country's position as a regional leader in the field of nuclear technology.
Overview
Our goal is to create a unique enterprise for the production of cyclotron products that will meet high international standards and meet the needs of the healthcare sector with an emphasis on innovation, radiation risk reduction and reliability.
Marketing research has shown a growing demand for radioisotopes and radioisotope products, so we will offer a wide range for the medical industry, as well as for academic and clinical research.
Uzbekistan's contribution to world science
Uzbekistan's unique experience in isotope production
-
Germanium-68 and Gallium-68
The Institute of Nuclear Physics has developed unique technologies for the production of radionuclides, including germanium-68 and a gallium-68 generator based on it, which are widely used in nuclear medicine.
-
Lutetium-177
The Institute has also developed technologies for the production of iridium-192 and other sought-after radionuclides such as caesium-131, iodine-125, samarium-153 and lutetium-177.
-
Cobalt-57
Cobalt-57 is another important radionuclide, the production technology of which has been successfully mastered by the institute. This isotope is widely used in diagnostics and calibration of equipment.
Local access to radioactive isotopes
-
Accessibility of medical care
Hospitals, clinics and medical research institutions in Uzbekistan will have local access to radioactive isotopes, which will increase the likelihood of accurate diagnosis and monitoring of patients' condition.
-
Diagnostic efficiency
The information provided during nuclear medicine examinations is unique and often unattainable when using other imaging techniques.
-
New areas of research
This will generate interesting new research that may lead to a deeper understanding of diseases and their treatment.
-
Detection of diseases
Local access to radioactive isotopes will increase the likelihood of timely diagnosis of various diseases, which will allow treatment to begin at an early stage.
-
New areas of research
The availability of radioactive isotopes will open up new research opportunities that can lead to a better understanding of diseases and their treatment.
-
Benefits of nuclear medicine
Nuclear medicine is more accurate and cost-effective than invasive surgical methods of diagnosis and treatment.
Launching a cyclotron facility in Uzbekistan will significantly increase local production and export of high-tech radioisotope products, meeting the demand of markets in Central Asia and beyond.
A cyclotron complex in Uzbekistan will facilitate the joint development and production of innovative radiopharmaceuticals that meet the needs of medicine, industry and scientific research.
Introducing an additional player in the radioisotope market in Uzbekistan, along with the existing enterprise, will contribute to the development of healthy market competition, which will promote innovation and fair commercial conditions.
Uzbekistan's location between Asia, Europe and Africa on the new Southern Silk Road provides optimal conditions for trade and economic cooperation with countries of fast-growing emerging markets.
Thanks to the developed system of international airports in Uzbekistan, important places in the country can be quickly and conveniently reached from anywhere in the world in just a few hours.
The cyclotron facility in Uzbekistan will create a wide range of new highly qualified jobs in the fields of nuclear medicine, oncology, physics and related disciplines.
The project will also provide opportunities for internships, postgraduate studies and continuous professional development of young scientists and specialists
Highly qualified doctors, physicists, engineers and technical specialists will occupy key positions to ensure the efficient operation of the cyclotron facility.
Nuclear medicine brings together professionals from various fields - physicists, chemists, engineers, biologists and doctors - to work together to study physiological processes and the development of diagnostic and therapeutic methods.
Using nuclear medicine, molecular imaging and radionuclide therapy in the treatment of diseases has expanded significantly over the past 80 years, opening up new possibilities in diagnosis and treatment.
Opening a cyclotron facility in Uzbekistan will help stimulate research in various fields of medicine, including neurology, pharmacology and preventive medicine.
Project significance
-
Improving the sustainability of supply chains
The COVID-19 pandemic has exposed vulnerabilities in global supply chains of medical equipment and drugs. This highlights the importance of strengthening domestic production capabilities to avoid future shocks.
-
Stimulating the local pharmaceutical industry
The expansion of pharmaceutical and biopharmaceutical production in Uzbekistan will increase the demand for local production of medicines, creating conditions for the sustainable development of the industry.
-
Creating a reliable healthcare ecosystem
The development of the cyclotron facility will lay the foundation for the formation of an integrated and sustainable healthcare system in Uzbekistan, combining modern diagnostic and therapeutic technologies.
-
Strengthening public-private partnerships
Cooperation between the public and private sectors will effectively combine resources, talents, technology and financing to achieve both commercial and social development goals.
Product range
- Telephone +971585310350 +998911620420
- E-mail info@gammasystematics.com
- Adress
